Concepedia
Statistics
Publications
50
Citations
5.4K
H-Index
31
Active since
2007
Affiliations
Promega (United States)(Current)
Goethe University Frankfurt
University of Oxford
University of Nottingham
Genomics (United Kingdom)
Matthew B. Robers is an author at Promega (United States) specializing in drug discovery, pharmacology, and life sciences.
Publications per year
2007–2025
Engineered Luciferase Reporter from a Deep Sea Shrimp Utilizing a Novel Imidazopyrazinone Substrate
Mary P. Hall, James Unch, Brock F. Binkowski et al. · ACS Chemical Biology · 2012 · 1.7K citations · Full text
Life Sciences, Biochemistry, Biotechnology +13
NanoBRET—A Novel BRET Platform for the Analysis of Protein–Protein Interactions
Thomas Machleidt, Carolyn C. Woodroofe, Marie K. Schwinn et al. · ACS Chemical Biology · 2015 · 496 citations · Full text
Natural Sciences, Biophysics, Molecular Biology +17
Quantitative Live-Cell Kinetic Degradation and Mechanistic Profiling of PROTAC Mode of Action
Kristin M. Riching, Sarah D. Mahan, Cesear Corona et al. · ACS Chemical Biology · 2018 · 320 citations · Full text
Life Sciences, Biochemistry, Cell Biology +15
Quantitative, Wide-Spectrum Kinase Profiling in Live Cells for Assessing the Effect of Cellular ATP on Target Engagement
James D. Vasta, Cesear Corona, Jennifer Wilkinson et al. · Cell chemical biology · 2017 · 293 citations · Full text
Pharmacy, Medicinal Chemistry, Pharmacology +14
Target engagement and drug residence time can be observed in living cells with BRET
Matthew B. Robers, Melanie L. Dart, Carolyn C. Woodroofe et al. · Nature Communications · 2015 · 286 citations · Full text
Medicine, Medicinal Chemistry, Pharmacology +15
1–5 of 50